These results suggest that the inhibition of HMGCR and CETP and the activation of LPL may have a protective effect against migraine, while the inhibition of PCSK9, APOB, and NPC1L1 and the activation of ABCG5/ABCG8 may contribute to migraine (Table S18). This evidence concerns the gene PCSK9 and migraine disorder.